The data was presented at the European Society for Paediatric Infectious Diseases (ESPID) congress in Lisbon, Portugal. The trial involved subjects aged 10 to 25 who received the vaccine as two ...

The European Alliance of Associations for Rheumatology, in partnership with the Pediatric Rheumatology European Society (PReS ...

Data for this review were identified by searches of databases and cross-references from relevant articles. Literature searches were conducted in January, February and March 2009 on Ovid for ...

New data highlight an alarming link between SARS-CoV-2 and the development of T2D in children and adolescents. Learn more.

A recent breakthrough study has introduced a novel methodology that significantly enhances the accuracy of epidemiological estimates for infectious diseases like COVID-19. A recent breakthrough ...

Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitisApproval based on phase 3 data showing ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

In: European Society of Clinical Microbiology and Infectious Diseases; 2024. 12. Mann E, Wilson C, Klein E. Impact of a novel host-response diagnostic on emergency department antibiotic ...

Integrating genomics into the public health architecture for effective monitoring, prevention, and mitigation of infectious diseases using next-generation sequencing (NGS) technology.

The Vaccine and Infectious Disease Division (VIDD) is a recognized leader in translational and “bench-to-bedside” science. VIDD integrates the expertise and creativity of scientists in basic, ...